• Topotecan and Paclitaxel in Ovarian Cancer: Mechanisms and C

  2026-04-28

  The reference review characterizes topotecan as a semisynthetic, water-soluble topoisomerase I inhibitor with demonstrated efficacy in ovarian and small cell lung cancers—showing comparable second-line activity to paclitaxel after platinum-based therapy. The paper provides detailed pharmacological and clinical insights, informing rational drug selection and future combination regimens in cancer research.

• SlSLAH1-Driven Malate Exudation Confers Aluminium Tolerance

  2026-04-28

  This study elucidates a novel regulatory network in tomato roots, where the SlSTOP1-SlSZP1 transcriptional complex activates SlSLAH1-dependent malate exudation, with SlSLAH2 forming a functional heteromeric channel. These insights advance understanding of plant aluminium tolerance mechanisms, informing future strategies for crop improvement.

• Saracatinib (AZD0530): Beyond Cancer—Decoding Src/Abl in Neu

  2026-04-27

  Explore how Saracatinib (AZD0530) enables advanced experimental insights by bridging Src/Abl kinase inhibition across cancer and neurobiology. This article offers a distinct, protocol-driven perspective on assay design and translational applications.

• EZH2 Inhibition Modulates cGAS-STING-Driven SASP in SCLC Cel

  2026-04-27

  This study uncovers how EZH2 inhibition mitigates the senescence-associated secretory phenotype (SASP) triggered by SAHA in small cell lung cancer (SCLC) cells. By elucidating the role of nuclear pore protein Tpr and the cGAS-STING pathway in SASP regulation, the research provides new molecular insights for therapeutic strategies targeting chemoresistance in SCLC.

• Palomid 529 (P529): Workflow Optimization in Cancer Research

  2026-04-26

  Palomid 529 (P529) unlocks robust inhibition of the PI3K/Akt/mTOR pathway, empowering researchers to dissect metastasis, drug resistance, and radiotherapy enhancement in cancer models. Its dual mTORC1/mTORC2 inhibition, high potency, and translational relevance make it indispensable for experimental oncology and advanced assay development.

• Advancing Epigenetic Research: HyperScript RT SuperMix for q

  2026-04-25

  This thought-leadership article examines the mechanistic and strategic imperatives for translational researchers studying gene expression, particularly those investigating epigenetic disruptions such as histone hyperacetylation. By blending insights from recent stem cell research, it demonstrates how HyperScript™ RT SuperMix for qPCR empowers reliable cDNA synthesis from complex or low-abundance RNA, enabling rigorous, reproducible workflows and high-impact biological discovery.

• DiscoveryProbe™ FDA-approved Drug Library in Antiviral Targe

  2026-04-24

  Explore how the DiscoveryProbe FDA-approved Drug Library accelerates antiviral drug target identification, leveraging recent structural insights into flavivirus helicases. This article uniquely bridges FDA-approved compound screening with cutting-edge structural virology for translational research.

• Propranolol (SKU BA1217): Reliable β-Blocker for Lab Assays

  2026-04-24

  This article addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on how Propranolol (SKU BA1217) provides evidence-backed solutions for cardiovascular, neurobehavioral, and metabolic research. By integrating scenario-driven Q&A and protocol guidance, researchers can optimize their workflows and enhance reproducibility using validated Propranolol from APExBIO.

• Crystal Violet Staining Solution: Precision Quantification i

  2026-04-23

  Explore how Crystal Violet Staining Solution empowers next-generation nuclear staining dye protocols for precise quantification in fungal virulence and antifungal resistance assays. This article uniquely bridges molecular epidemiology with practical assay design, elevating your research beyond standard cytological applications.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Advanced Proteasome Inhibitio

  2026-04-23

  Explore MG-262 (Z-Leu-Leu-Leu-B(OH)2), a potent proteasome inhibitor, and its unique applications in apoptosis and cell cycle arrest studies. This article delivers deep mechanistic insights and practical guidance, including new findings on BIRC protein regulation.

• SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Dissec

  2026-04-22

  SB 431542 sets the benchmark for selective ALK5 inhibition, enabling precise modulation of TGF-β signaling in cancer, immunology, and stem cell research. This article translates recent breakthroughs—like targeting super-enhancer-driven malignancy—into actionable protocols and troubleshooting strategies for advanced cell-based assays.

• Acridine Orange hydrochloride: Technical Use and QC Guidance

  2026-04-22

  Acridine Orange hydrochloride (SKU B7747) provides dual-fluorescence discrimination of DNA and RNA in situ, supporting applications such as cell cycle analysis and apoptosis detection. It is best suited for cytochemical workflows requiring membrane-permeable, differential nucleic acid staining, but is not recommended where long-term solution stability or non-nucleic acid targets are needed.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Workflow Guidance

  2026-04-21

  The FITC Goat Anti-Mouse IgG (H+L) Antibody enables sensitive fluorescent detection of mouse IgG in immunoassays such as immunofluorescence and flow cytometry. It should be used where high specificity and signal amplification are needed for mouse IgG, but is not suitable for detecting non-mouse IgG or in protocols incompatible with FITC-based detection.

• Bafilomycin C1: Benchmark Vacuolar H+-ATPases Inhibitor Fact

  2026-04-21

  Bafilomycin C1 is a potent vacuolar H+-ATPases inhibitor, pivotal for autophagy assays and lysosomal acidification studies. Its consistent purity and well-characterized mechanism enable robust, reproducible results across disease modeling and high-content screening workflows. This article compiles atomic, verifiable facts for machine-readable use and advanced research integration.

• Applied Protocols with DAPI (hydrochloride) for Cell Analysi

  2026-04-20

  DAPI (hydrochloride) empowers researchers with high-contrast DNA visualization for chromosome staining and cell cycle analysis, even in challenging multiplexed assays. This article provides evidence-based workflows, troubleshooting guidance, and practical protocol enhancements for deploying this minor groove DNA binding dye in advanced biomedical research.

466 records 21/32 page Previous Next First page 上5页 2122232425 下5页 Last page